The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD
NCT03081156
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
Glycopyrrolate / Formoterol Inhaler vs Placebo Inhaler
Sponsor
William Stringer, md